Meeting
2023 ASCO Annual Meeting
Pretreatment clinical parameters associated with intracranial progression burden following an initial stereotactic radiosurgery course in a multi-institutional brain metastases cohort.
Authors
Christina C Huang
Department of Radiation Oncology, Duke University Medical Center, Durham, NC
Christina C Huang , Jamiluddin Qazi , Jim Leng , David James Carpenter , Brahma Darshni Natarajan , Muzamil Arshad , Olivia Schultz , Michael James Moravan , Trey Carlton Mullikin , Zach Reitman , John P Kirkpatrick , Scott R. Floyd , Steven J. Chmura , Julian C. Hong , Joseph Kamel Salama
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 2013)
DOI
10.1200/JCO.2023.41.16_suppl.2013
Abstract #
2013
Poster Bd #
370
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Brain metastasis burden and management in small cell lung cancer: An analysis of 8705 patients.
First Author: Karolina Gaebe
Poster
2021 ASCO Annual Meeting
Predictors of overall survival (OS) in patients (pts) with melanoma brain metastasis (MBM) in the modern era.
First Author: Merve Hasanov
Poster
2021 ASCO Annual Meeting
Patterns of survival in NSCLC with de novo brain metastasis: SRS, WBRT, and no radiotherapy cohorts.
First Author: Diana Saravia
Poster
2017 ASCO Annual Meeting
What drives patient outcomes in brain metastases: Number, volume, or biology?
First Author: Rupesh Kotecha